10May/13

Asbestos Disease Awareness Organization Outraged that Seven Countries … – MarketWatch (press release)

Asbestos Disease Awareness Organization Outraged that Seven Countries
MarketWatch (press release)
Of the 143 countries attending the conference, seven countries – India, Kazakhstan, Kyrgyzstan, the Russian Federation, Ukraine, Vietnam, and Zimbabwe – opposed the listing. “Asbestos-related diseases “Chrysotile asbestos is recognized by every

and more »

10May/13

Lilly Halts Drug Development After Failed Trial – Inside INdiana Business (press release)


Dividend.com

Lilly Halts Drug Development After Failed Trial
Inside INdiana Business (press release)
The study failed to show a statistically significant increase compared to placebo in disease-free survival in patients at high risk of relapse following rituximab-based chemotherapy. There were no new safety findings, and the safety data were
Lilly To Take $30M Charge After Relapse Cancer Drug Disappoints in TrialFox Business
Enzastaurin, Eli Lilly’s Lymphoma Drug Fails In Late-Stage TrialMedical Daily
Lilly Halts Development of Lymphoma Drug After Phase III FailureGenetic Engineering News

all 15 news articles »

10May/13

Geisinger Partners with Indivumed for Personalized Medicine Initiative – Newswise – Newswise (press release)

Geisinger Partners with Indivumed for Personalized Medicine Initiative – Newswise
Newswise (press release)
Indivumed follows highly standardized processes that enable the company to limit cold ischemia time – the time between removal of tissue from the body and the time it is preserved – to less than 10 minutes, guaranteeing tissue samples maintain their

and more »